ACKR3 and Hepatic fibrosis: In vivo experiments demonstrated that TC14012 enhanced the therapeutic potential of UC-MSCs for liver fibrosis by reducing collagen fiber accumulation, restoring CXCR7 expression, and inhibiting inflammatory infiltration (Fig. 7).